Treatment of intermittent claudication with beraprost sodium, an orally active prostaglandin I2 analogue: Double-blinded, randomized, controlled trial

Journal of the American College of Cardiology

Volumn 41, Issue 10, 2003, Pages 1679-1686

  Mohler III, Emile R ^a   Hiatt, William R ^b   Olin, Jeffrey W ^c   Wade, Michael ^d   Jeffs, Roger ^d   Hirsch, Alan T ^e  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d UNITED THERAPEUTICS CORPORATION   (United States)

^e UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BERAPROST; PLACEBO; PROSTACYCLIN DERIVATIVE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG ACTIVITY; DRUG EFFICACY; FEMALE; HEADACHE; HEART DEATH; HEART INFARCTION; HUMAN; INTERMITTENT CLAUDICATION; LIMB ISCHEMIA; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEAL; MULTICENTER STUDY; NAUSEA; PAIN; PAIN ASSESSMENT; PARAMETER; PERFORMANCE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TREADMILL EXERCISE; TREATMENT FAILURE; TREATMENT OUTCOME; VASODILATATION; WALKING;

EID: 0038025289     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(03)00299-7     Document Type: Article

References (19)

1. Criqui MH, Fronek A, Barrett-Connor E, Klauber MR, Gabriel S, Goodman D. The prevalence of peripheral arterial disease in a defined population. Circulation 1985;71:510-5.
2. Hirsch AT, Criqui MH, Treat-Jacobson D, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 2001;286:1317-24.
3. Hiatt WR, Regensteiner JG, Hargarten ME, Wolfel EE, Brass EP. Benefit of exercise conditioning for patients with peripheral arterial disease. Circulation 1990;81:602-9.
4. Klugherz B, Mohler ER III. Current and emerging therapies for lower extremity peripheral arterial disease. ACC Curr J Rev 2001;9:37-9.
5. Hiatt WR. Medical treatment of peripheral arterial disease and claudication. N Engl J Med 2001;344:1608-21.
6. Hirsch AT, Reich M. Intermittent claudication. Curr Treat Options Cardiovasc Med 2001;3:167-80.
7. Reilly MP, Mohler ER III. Cilostazol: treatment of intermittent claudication. Ann Pharmacother 2001;35:48-56.
8. Dawson DL, Cutler BS, Meissner MH, Strandness DEJ. Cilostazol has beneficial effects in treatment of intermittent claudication: results from a multicenter, randomized, prospective, double-blind trial. Circulation 1998;98:678-86.
9. Beebe HG, Dawson DL, Cutler BS, et al. A new pharmacological treatment for intermittent daudication: results of a randomized, multicenter trial. Arch Intern Med 1999;159:2041-50.
10. Dawson DL, Cutler BS, Hiatt WR, et al. A comparison of cilostazol and pentoxifylline for treating intermittent claudication. Am J Med 2000;109:523-30.
11. Vane JR, Botting RM. Pharmacodynamic profile of prostacyclin. Am J Cardiol 1995;75:3-10A.
12. Friedman R, Mears JG, Barst RJ. Continuous infusion of prostacyclin normalizes plasma markers of endothelial cell injury and platelet aggregation in primary pulmonary hypertension. Circulation 1997;96:2782-4.
13. Willis AL, Smith DL, Vigo C, Kluge AF. Effects of prostacyclin and orally active stable mimetic agent RS-93427-007 on basic mechanisms of atherogenesis. Lancet 1986;2:682-3.
14. Demolis JL, Robert A, Mouren M, Funck-Brentano C, Jaillon P. Pharmacokinetics and platelet antiaggregating effects of beraprost, an oral stable prostacyclin analogue, in healthy volunteers. J Cardiovasc Pharmacol 1993;22:711-6.
15. Nony P, Ffrench P, Girard P, et al. Platelet-aggregation inhibition and hemodynamic effects of beraprost sodium, a new oral prostacyclin derivative: a study in healthy male subjects. Can J Physiol Pharmacol 1996;74:887-93.
16. 2 analogue, for intermittent claudication: a double-blind, randomized, multicenter controlled trial. Circulation 2000;102:426-31.
17. Labs KH, Nehler MR, Roessner M, Jaeger KA, Hiatt WR. Reliability of treadmill testing in peripheral arterial disease: a comparison of a constant load with a graded load treadmill protocol. Vasc Med 1999;4:239-46.
18. Regensteiner JG, Gardner A, Hiatt WR. Exercise testing and exercise rehabilitation for patients with peripheral arterial disease: status in 1997. Vasc Med 1997;2:147-55.
19. Lievre M, Azoulay S, Lion L, Morand S, Girre JP, Boissel JP. A dose-effect study of beraprost sodium in intermittent claudication. J Cardiovasc Pharmacol 1996;27:788-93.